C-TPF in Patients With Newly Diagnosed Locally Advanced Squamous Cell Carcinoma of the Head and Neck

NCT00402545 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

29

Enrollment

OTHER

Sponsor class

Conditions

Head and Neck Neoplasms

Interventions

DRUG: Cetuximab
DRUG: Docetaxel
DRUG: Cisplatin
DRUG: 5-Fluorouracil

Sponsor

Dana-Farber Cancer Institute

Collaborators

[object Object]
[object Object]